In situ-forming gels for ophthalmic drug delivery
S Kumar1, B O Haglund, K J Himmelstein
1Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha.
Summary
This study developed a novel in situ-forming ophthalmic drug delivery system using Carbopol and methyl cellulose. The system gels at physiological conditions, enhancing drug bioavailability by increasing eye residence time.
Area of Science:
- Polymer Science
- Materials Science
- Ophthalmology
Background:
- Ophthalmic drug delivery faces challenges with poor bioavailability due to dilution and drainage.
- In situ-forming systems utilizing polymers with reversible phase transitions offer a solution.
- Previous work demonstrated gelation in response to multiple physical parameter variations.
Purpose of the Study:
- To characterize the rheological properties of a Carbopol (C) and methyl cellulose (MC) based in situ-forming ophthalmic drug delivery system.
- To evaluate the effect of pH and temperature variations on the system's viscosity and gelation.
- To identify an optimal formulation for enhanced ocular drug delivery.
Main Methods:
- Rheological characterization using rotational cone and plate viscometry.
- Testing at varying pH (4.0 and 7.4) and temperatures (25 and 37°C).
- Analysis of shear stress vs. shear rate flow curves to determine pseudoplastic behavior and yield point.
Main Results:
- The polymer solutions exhibited pseudoplastic behavior with a yield point.
- Increased pH and temperature led to higher viscosity, shear stress, and yield point.
- Simultaneous changes in pH and temperature had the most significant impact on rheological properties.
- A formulation of 1.5% MC and 0.3% C showed low initial viscosity and formed a strong gel under physiological conditions.
Conclusions:
- The Carbopol-methyl cellulose system demonstrates tunable rheological properties responsive to environmental changes.
- The optimized formulation effectively transitions from liquid to gel at physiological conditions.
- This in situ-forming system has the potential to improve ocular drug bioavailability by increasing precorneal residence time.


